RARA CRAFT DATABASE for FDA Medical Devices
510(k)K230681

FDA DEVICE FACTS

Blue Non Sterile Powder Free Nitrile Examination Gloves Tested for Use with Chemotherapy Drugs, with Gastric Acid and Fentanyl

Central Medicare Sdn Bhd

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEOctober 2, 2023PRODUCT CODELZA

Indications for use

Blue Non Sterile Powder Free Nitrile Examination Gloves, Tested for Use with Chemotherapy Drugs, with Gastric Acid and Fentanyl is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner . In addition, these gloves were tested for use with chemotherapy drugs, with gastric acid and fentanyl citrate in accordance with ASTM D6978-05. Tested chemotherapy drugs and breakthrough detection time (minutes) are as follows: Chemotherapy Drug Concentration Breakthrough Detection Time in Minutes Arsenic Trioxide 1.0mg/ml > 240 minutes Azacitidine (Vidaza) 25.0 mg/ml > 240 minutes Bendamustine HCl 5.0mg/ml > 240 minutes Bleomycin Sulfate 15.0mg/ml > 240 minutes Busulfan 6.0 mg/ml > 240 minutes Carboplatin 10.0 mg/ml > 240 minutes Carmustine (BCNU) 3.3 mg/ml 5 5 .1 minutes Carfilzomib 2.0 mg/ml > 240 minutes Cetuximab 2.0 mg/ml > 240 minutes Chloroquine 50.0mg/ml > 240 minutes Cisplatin 1.0mg/ml > 240 minutes Cladribine 1.0 mg/ml > 240 minutes Cyclophosphamide ( Cytoxan) 20.0 mg/ml > 240 minutes Cyclosporin A 100.0 mg/ml > 240 minutes Cytarabine 100.0 mg/ml > 240 minutes Cytovene (Ganciclovir) 10.0mg/ml > 240 minutes Dacarbazine 10.0 mg/ml > 240 minutes Daunorubicin 5.0 mg/ml > 240 minutes Decitibine 5.0 mg/ml > 240 minutes Docetaxel 10.0 mg/ml > 240 minutes Doxorubicin Hydrochloride 2.0 mg/ml > 240 minutes Epirubicin (Ellence) 2.0 mg/ml > 240 minutes Etoposide (Toposar) 20.0 mg/ml > 240 minutes Fludarabine 25.0 mg/ml > 240 minutes Fluorouracil 50.0 mg/ml > 240 minutes Fulvestrant 50.0mg/ml > 240 minutes Gemcitabine (Gemzar) 38.0 mg/ml > 240 minutes Idarubicin 1.0mg/ml > 240 minutes lfosfamide 50.0 mg/ml > 240 minutes Irinotecan 20.0 mg/ml > 240 minutes Mechlorethamine HCl 1.0 mg/ml > 240 minutes Melphalan 5.0 mg/ml > 240 minutes Mesna 50.0 mg/ml > 240 minutes Methotrexate 25.0 mg/ml > 240 minutes Mitomycin C 0.5 mg/ml > 240 minutes Mitoxantrone 2.0 mg/ml > 240 minutes Oxaliplatin 2.0 mg/ml > 240 minutes Paclitaxel 6.0 mg/ml > 240 minutes Paraplatin 10.0 mg/ml > 240 minutes Pemetrexed 25.0 mg/ml > 240 minutes Pertuzumab 30.0 mg/ml > 240 minutes Propofol 10.0 mg/ml > 240 minutes Raltitrexed 0.5 mg/ml > 240 minutes Retrovir 10.0 mg/ml > 240 minutes Rituximab 10.0 mg/ml > 240 minutes Temsirolimus 25.0 mg/ml > 240 minutes Thiotepa 10.0 mg/ml 98.7 minutes Topotecan HCl 1.0 mg/ml > 240 minutes Trastuzumab 21.0 mg/ml > 240 minutes Triclosan 2.0 mg/ml > 240 minutes Trisenox (Arsenic Trioxide) 1.0 mg/ml > 240 minutes Velcade (Bortezomib) 1.0 mg/ml > 240 minutes Vinblastine 1.0 mg/ml > 240 minutes Vincristine Sulfate 1.0 mg/ml > 240 minutes Vinorelbine 10.0 mg/ml > 240 minutes Zoledronic Acid 0.8 mg/ml > 240 minutes Under the testing conditions of ASTM D6978-05, Fentanyl Citrate Injection (100mcg/2mL) was found to have no breakthrough detected up to 240 minutes. Under the testing conditions of ASTM D6978-05, Gastric Acid was found to have no breakthrough detected up to 240 minutes. CAUTION: Testing showed breakthrough time of 55.1 minutes with Carmustine and 98.7 minutes with Thiotepa. WARNING: Do not use with Carmustine and Thiotepa.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 18, 2026